MeritValue

BLUE BIOFUELS, INC.

BIOFdata completeness 75%12 fiscal years on file

Data notes: no data for concept 'incomeTaxExpense'; no data for concept 'pretaxIncome'

i. The business — what you’d actually own
FigureFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue—————
Net income−$2.14M1−$3.96M2−$3.06M3−$1.42M4−$2.87M4
Operating cash flow−$2.47M5−$2.04M6−$1.6M7−$1M8−$845,0028
Capital expenditure$216,3909$138,17010$287,82811$71,13812$68,89812
Free cash flow (derived)−$2.68M5−$2.17M6−$1.89M7−$1.07M8−$913,9008
Total debt—————
Cash & equivalents$1.16M13$211,90114$41,00815$48,79716$65,20016
Diluted shares269.6M278.8M300.0M303.9M312.2M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0.12
your share of equity
Profit it earned you last year
−$0.09
Free cash flow it threw off
−$0.03
Debt you’d be carrying
—

10 shares is a claim on −$0.12 of net worth that earned you −$0.09 and generated −$0.03 of cash last year.

iii. Is this a good business?
Moat signal · return on equity
— avg · 5y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
+16% shares · 5y

Share count is up 16% over 5 years — owners have been diluted. Worth asking what they got for it.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
DCF · Growth Exit 5Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2021-12-31 · accession 0001493152-23-010103 (NetIncomeLoss)
  2. 10-K · period ending 2022-12-31 · accession 0001493152-24-011318 (NetIncomeLoss)
  3. 10-K · period ending 2023-12-31 · accession 0001493152-25-010854 (NetIncomeLoss)
  4. 10-K · period ending 2024-12-31 · accession 0001493152-26-011555 (NetIncomeLoss)
  5. 10-K · period ending 2021-12-31 · accession 0001493152-23-010103 (NetCashProvidedByUsedInOperatingActivities)
  6. 10-K · period ending 2022-12-31 · accession 0001493152-24-011318 (NetCashProvidedByUsedInOperatingActivities)
  7. 10-K · period ending 2023-12-31 · accession 0001493152-25-010854 (NetCashProvidedByUsedInOperatingActivities)
  8. 10-K · period ending 2024-12-31 · accession 0001493152-26-011555 (NetCashProvidedByUsedInOperatingActivities)
  9. 10-K · period ending 2021-12-31 · accession 0001493152-23-010103 (PaymentsToAcquirePropertyPlantAndEquipment)
  10. 10-K · period ending 2022-12-31 · accession 0001493152-24-011318 (PaymentsToAcquirePropertyPlantAndEquipment)
  11. 10-K · period ending 2023-12-31 · accession 0001493152-25-010854 (PaymentsToAcquirePropertyPlantAndEquipment)
  12. 10-K · period ending 2024-12-31 · accession 0001493152-26-011555 (PaymentsToAcquirePropertyPlantAndEquipment)
  13. 10-K · period ending 2021-12-31 · accession 0001493152-23-010103 (CashAndCashEquivalentsAtCarryingValue)
  14. 10-K · period ending 2022-12-31 · accession 0001493152-24-011318 (CashAndCashEquivalentsAtCarryingValue)
  15. 10-K · period ending 2023-12-31 · accession 0001493152-25-010854 (CashAndCashEquivalentsAtCarryingValue)
  16. 10-K · period ending 2024-12-31 · accession 0001493152-26-011555 (CashAndCashEquivalentsAtCarryingValue)